1. Halozyme Therapeutics Inc.
  2. Halozyme Therapeutics Inc. Ownership

Historical shareholding details of Nuveen Asset Management, LLC holdings in Halozyme Therapeutics Inc. (HALO)

Monthly changes of Nuveen Asset Management, LLC shareholding in Halozyme Therapeutics Inc. over the previous months

Month Name Total no. shares held Percent Holding
Feb 28, 2025 Nuveen Asset Management, Llc 72,231 0.06%
Jan 31, 2025 Nuveen Asset Management, Llc 71,406 0.06%
Dec 31, 2024 Nuveen Asset Management, Llc 1,530,519 1.24%
Dec 31, 2024 Nuveen Asset Management, Llc 71,406 0.06%
Nov 30, 2024 Nuveen Asset Management, Llc 75,451 0.06%
Oct 31, 2024 Nuveen Asset Management, Llc 75,451 0.06%
Sep 30, 2024 Nuveen Asset Management, Llc 1,539,153 1.25%
Sep 30, 2024 Nuveen Asset Management, Llc 75,451 0.06%
Aug 31, 2024 Nuveen Asset Management, Llc 93,522 0.07%
Jul 31, 2024 Nuveen Asset Management, Llc 93,522 0.07%
Jun 30, 2024 Nuveen Asset Management, Llc 1,601,598 1.26%
Jun 30, 2024 Nuveen Asset Management, Llc 109,609 0.09%
May 31, 2024 Nuveen Asset Management, Llc 109,609 0.09%
Apr 30, 2024 Nuveen Asset Management, Llc 109,609 0.09%
Mar 31, 2024 Nuveen Asset Management, Llc 1,651,610 1.30%
Mar 31, 2024 Nuveen Asset Management, Llc 109,609 0.09%
Feb 29, 2024 Nuveen Asset Management, Llc 92,680 0.07%
Jan 31, 2024 Nuveen Asset Management, Llc 92,680 0.07%
Dec 31, 2023 Nuveen Asset Management, Llc 1,525,202 1.20%
Dec 31, 2023 Nuveen Asset Management, Llc 93,488 0.07%
Nov 30, 2023 Nuveen Asset Management, Llc 93,488 0.07%
Oct 31, 2023 Nuveen Asset Management, Llc 93,488 0.07%
Sep 30, 2023 Nuveen Asset Management, Llc 1,544,846 1.22%
Sep 30, 2023 Nuveen Asset Management, Llc 93,488 0.07%
Aug 31, 2023 Nuveen Asset Management, Llc 93,488 0.07%
Jul 31, 2023 Nuveen Asset Management, Llc 93,488 0.07%
Jun 30, 2023 Nuveen Asset Management, Llc 1,362,705 1.03%
Jun 30, 2023 Nuveen Asset Management, Llc 83,558 0.06%
May 31, 2023 Nuveen Asset Management, Llc 83,558 0.06%
Mar 31, 2023 Nuveen Asset Management, Llc 1,234,558 0.94%
Dec 31, 2022 Nuveen Asset Management, Llc 995,536 0.76%

View all ownership details of Halozyme Therapeutics Inc.